Ixekizumab Chemically, it is a form of a humanized monoclonal antibody. In the United States, ixekizumab is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy, active psoriatic arthritis, active ankylosing spondylitis, and active non-radiographic axial spondyloarthritis with objective signs of inflammation. In the European Union it is indicated for the treatment of moderate-to-severe plaque psoriasis and as a second-line therapy for active psoriatic arthritis.<\/p>\n
If ixekizumab injection are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n
TALTZ (ixekizumab) injection, for subcutaneous use Initial U.S. Approval: 2016<\/p>\n
ixekizumab injection is a humanized interleukin-17A antagonist indicated for the treatment of: \u2022 patients aged 6 years or older with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. \u2022 adults with active psoriatic arthritis. \u2022 adults with active ankylosing spondylitis. \u2022 adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation.<\/p>\n
DISEASE INDICATIONS-Psoriasis If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import ixekizumab injection\u201d based on the information you provide.<\/p>\n
\nMANUFACTURER-Eli Lilly Nederland B.V.
\nUSAGE-Subcutaneous
\nMEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA)
\nSummary of FDA-approved use on approval date: Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n